Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,389 | -26,841 | -6,930 | -32,722 | -23,000 |
| Depreciation Amortization | 1,930 | 1,912 | 23 | 86 | 63 |
| Other Working Capital | 1,309 | 6,011 | -4,439 | -5,567 | -6,316 |
| Other Operating Activity | 1,986 | 1,289 | 1,217 | 6,979 | 5,411 |
| Operating Cash Flow | $-30,164 | $-17,629 | $-10,129 | $-31,225 | $-23,842 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2 | 2 | N/A | -130 | -130 |
| Investing Cash Flow | $2 | $2 | $N/A | $-130 | $-130 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -177 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 82,154 | 82,154 |
| Other Financing Activity | -2,000 | -2,000 | -2,000 | 0 | -177 |
| Financing Cash Flow | $-2,000 | $-2,000 | $-2,000 | $81,977 | $81,977 |
| Exchange Rate Effect | -42 | -14 | 3 | N/A | N/A |
| Beginning Cash Position | 91,349 | 91,349 | 91,349 | 40,727 | 40,727 |
| End Cash Position | 59,145 | 71,708 | 79,223 | 91,349 | 98,731 |
| Net Cash Flow | $-32,204 | $-19,642 | $-12,126 | $50,622 | $58,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,164 | -17,629 | -10,129 | -31,225 | -23,842 |
| Capital Expenditure | N/A | N/A | N/A | -130 | -130 |
| Free Cash Flow | -30,164 | -17,629 | -10,129 | -31,355 | -23,973 |